Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

By M. Lassen, W. Ageno, L. Borris, J. Lieberman, N. Rosencher, T. Bandel, F. Misselwitz, A. Turpie. New England Journal of Medicine, 2008

1,345 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/28e758b70de523a1ec3ba82abe59d3652948d9e9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. MD Sandra L. Kopp
2. MD Michael Tryba
3. MD David L. Brown
4. MD Honorio T. Benzon
5. MD PhD ÞÞ Chun-Su Yuan
6. MD L Richard W. Rosenquist
7. MD Michael F. Mulroy
8. MD Terese T. Horlocker

Citations in the corpus

• Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) (2009, methodology): “A recent comparison of once-daily rivaroxaban 10 mg with enoxaparin reported superiority with the rivaroxaban regimen (and the simplicity of oral administration).(189) Although a Bregional anesthetic[ was performed in more than half of the patients included in the clinical trials, no information reg”